Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism-related RNA changes in leukocytes after autologous mesenchymal stem cell transplantation
jRCT1030230333Recruiting
- Start
- Sep 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous mesenchymal stem cells in diseases that may respond to mesenchymal stem cell transplantation therapy, sponsored by none. Primary endpoint: Expression of metabolism-related RNAs in peripheral blood mononuclear cells. Started Sep 2023; status: recruiting.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
diseases that may respond to mesenchymal stem cell transplantation therapy
Beyond the preview
Go deeper on jRCT1030230333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030230333.